2-(6-fluoropyridin-3-yl)-1H-indole | 914389-95-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 2-(6-fluoropyridin-3-yl)-1H-indole
• CAS: 914389-95-0
• 化学式: C₁₃H₉FN₂
• 分子量: 212.226
• InChiKey: UUGNHALNYRTNGO-UHFFFAOYSA-N

物化性质

• 熔点：
  256 °C
• 沸点：
  425.8±30.0 °C(Predicted)
• 密度：
  1.289±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  28.7
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(6-fluoropyridin-3-yl)-1H-indole 以 四氢呋喃 为溶剂， 反应 3.0h， 生成 N-benzyl-2-(2-(6-fluoropyridin-3-yl)-1H-indol-3-yl)-2-oxoacetamide
  参考文献：
  名称：

  Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET

  摘要：

  A library of halogenated 2-arylindolyl-3-oxocarboxamides was prepared to develop radioligands to visualize cerebral PBR by SPECT and PET imaging. In vitro evaluation showed that most of the synthesized compounds were selective,high-affinity PBR ligands with adequate lipophilicity (log D(7.4) in the range of 1.6-2.4). The iodinated derivative 11 (K(i) = 2.6 nM) and the fluorinated analog 26 (K(i) = 6.2 nM) displayed higher affinity than reference compounds. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2006.07.001
• 作为产物：
  描述：

  吲哚-2-羧酸 在 四(三苯基膦)钯 叔丁基锂 、 potassium carbonate 作用下， 以 四氢呋喃 为溶剂， 反应 73.02h， 生成 2-(6-fluoropyridin-3-yl)-1H-indole
  参考文献：
  名称：

  Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET

  摘要：

  A library of halogenated 2-arylindolyl-3-oxocarboxamides was prepared to develop radioligands to visualize cerebral PBR by SPECT and PET imaging. In vitro evaluation showed that most of the synthesized compounds were selective,high-affinity PBR ligands with adequate lipophilicity (log D(7.4) in the range of 1.6-2.4). The iodinated derivative 11 (K(i) = 2.6 nM) and the fluorinated analog 26 (K(i) = 6.2 nM) displayed higher affinity than reference compounds. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2006.07.001

文献信息

• Novel Substituted Indoles
  申请人：Barrow James C.

  公开号：US20110076230A1

  公开（公告）日：2011-03-31

  The present invention relates to novel amyloid binding compounds and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted indole derivatives, compositions, and therapeutic uses and processes for making such compounds.

  本发明涉及新型淀粉样蛋白结合化合物及测量这些化合物的效果的方法，通过测量活体患者淀粉样斑块水平的变化。更具体地，本发明涉及使用这些化合物作为追踪剂在正电子发射断层扫描（PET）成像中研究大脑内的淀粉样沉积物，以诊断阿尔茨海默病。因此，本发明涉及将新型淀粉样蛋白结合化合物用作诊断工具。本发明还涉及测量阿尔茨海默病治疗药物的临床疗效的方法。具体而言，本发明涉及新型芳基或杂环芳基取代的吲哚衍生物、组成物和治疗用途以及制备这些化合物的过程。